Amy C. Moore: 2024 was an exciting year for lung cancer advances
Amy C. Moore, Vice President of Global Engagement and Patient Partnerships at LUNGevity Foundation, shared a post on X:
“2024 was an exciting year for lung cancer advances.
As we mark the 20th anniversary of the discovery of EGFR’s role in non-small cell lung cancer, we celebrate this era of precision medicine that is extending and improving patients’ lives.”
Amy C. Moore is the Vice President of Global Engagement and Patient Partnerships at LUNGevity Foundation. She previously served as the Director of Science & Research at the Addario Lung Cancer Medical Institute (ALCMI). She has published peer-reviewed papers on virology, cancer, and biomarker testing in NSCLC. Dr. Moore is also an expert on COVID-19’s impact on lung cancer and serves on several advisory boards.
More posts featuring Amy C. Moore.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023